Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3–MAPK/ERK pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3–MAPK/ERK pathway

Published:2012-04 Issue:2 Volume:420 Page:385-390
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Ruan Shu-Qin,Wang Zhan-Huai,Wang Shan-Wei,Fu Zhi-Xuan,Xu Kan-Lun,Li Dong-Bo,Zhang Su-Zhan

Funder

National Natural Science Foundation of China

The Research Fund for the Doctoral Program of Higher Education

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference31 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Update on endocrine therapy for breast cancer;Buzdar;Clin. Cancer Res.,1998

3. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release;Filardo;Trends Endocrinol. Metab.,2005

4. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF;Filardo;Mol. Endocrinol.,2000

5. GPR30: a novel therapeutic target in estrogen-related disease;Prossnitz;Trends Pharmacol. Sci.,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance;Cancer Letters;2024-09

2. Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice;International Journal of Molecular Sciences;2024-06-06

3. Growth Factor Receptor Implications in Breast Cancer: Prospects for Their Molecular Transactivation in the Future and Obstacles for Target Therapy;Interdisciplinary Cancer Research;2024

4. Development and performance evaluations of an HER-2 kit;Analytical Biochemistry;2023-07

5. Natural bioactive compounds as a new source of promising G protein-coupled estrogen receptor (GPER) modulators: comprehensive in silico approach;Journal of Biomolecular Structure and Dynamics;2020-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3